Eine zielgenaue Bewerbung für diesen Job — ein maßgeschneiderter Lebenslauf und ein Anschreiben, die genau zur Stellenanzeige passen.
ETH Zürich's Neurotechnology Group invites applications for PhD candidates to advance a focused ultrasound-driven drug delivery platform toward clinical translation.
You will develop next-generation ultrasound systems, perform preclinical validation, and collaborate with clinicians across ETH Zurich, University Hospital Zurich, and related institutes to enable targeted brain therapies.
100%, Zurich, fixed-term
print Drucken
The Neurotechnology Group of Prof. Mehmet Fatih Yanik at ETH Zurich is recruiting outstanding PhD students to join a newly funded LOOP Zurich Flagship Project focused on advancing a breakthrough technology to clinic for non-invasive targeted drug delivery to the brain. Our laboratory recently developed a novel focused ultrasound-mediated targeted drug delivery platform, published in Nature Communications, that enables localized, hyper-efficient delivery of therapeutic compounds to specific brain regions without invasive surgery.
Project background
We develop advanced focused ultrasound technologies, adaptive closed-loop control algorithms, and ultrasound-responsive micro/nano therapeutic carriers as an integrated precision drug delivery platform for the brain. Our approach employs a novel two-component ultrasound strategy that first concentrates drug carriers within the target region and subsequently triggers localized drug release, achieving high therapeutic concentrations exclusively at the desired site while minimizing systemic exposure. To ensure safe, precise, and reproducible therapy, the platform continuously monitors acoustic emissions from carriers, automatically adjusts ultrasound exposure in real time, and preserves blood-brain barrier integrity. By integrating therapeutic carrier design, robotics, medical imaging, real-time sensing, and intelligent control into a unified system, this technology establishes a new paradigm for precision neurotherapeutics and opens new opportunities for treating epilepsy, brain tumors, neurodegenerative diseases, psychiatric disorders, and other neurological disorders. The long-term goal of this project is to establish this technology as a clinically applicable therapeutic platform by integrating targeted drug delivery with advanced neuroimaging, electrophysiology, and closed-loop neuromodulation. The primary objective of this PhD project is to advance this technology from proof-of-concept toward clinical translation. Successful candidates will further develop the technology, investigate its therapeutic potential for neurological disorders, perform preclinical validation in rodent and large-animal models, and contribute to the preparation of first-in-human clinical studies. The project is conducted in close collaboration with Swiss Epilepsy Clinic Lengg, the Department of Neurosurgery at University Hospital Zurich, and the Vetsuisse Faculty of the University of Zurich.
The successful candidate will play a central role in the development and translation of our focused ultrasound-mediated targeted drug delivery platform.
This is a highly interdisciplinary project at the interface of neuroscience, biomedical engineering, physics, electrical engineering, medical imaging, robotics, and translational medicine.
We are looking for highly motivated and creative researchers who enjoy solving challenging interdisciplinary problems.
Applicants should hold a Master's degree in one of the following disciplines:
Because the project includes translational preclinical studies, candidates should be willing to participate in animal experiments.
Workplace
Students will collaborate closely with scientists and clinicians across ETH Zurich, the University of Zurich, University Hospital Zurich, and Klinik Lengg.
The successful candidate will be enrolled as a PhD student in the Department of Information Technology and Electrical Engineering (D-ITET) at ETH Zurich, member of the Institute of Neuroinformatics, and the Neuroscience Center Zurich (ZNZ) PhD Program.
chevron_right Working, teaching and research at ETH Zurich
We value diversity and sustainability
In line with our values, ETH Zurich encourages an inclusive culture. We promote equality of opportunity, value diversity and nurture a working and learning environment in which the rights and dignity of all our staff and students are respected. Visit our Equal Opportunities and Diversity website to find out how we ensure a fair and open environment that allows everyone to grow and flourish. Sustainability is a core value for us – we are consistently working towards a climate-neutral future.
Curious? So are we.
September 2026 (earlier or later starting dates are possible for exceptional candidates)
Further information about the Neurotechnology Group can be found on our Website. Questions regarding the position should be directed to ntjobs@ethz.ch (no applications).
We would like to point out that the pre-selection is carried out by the responsible recruiters and not by artificial intelligence.
ETH Zurich is one of the world’s leading universities specialising in science and technology. We are renowned for our excellent education, cutting-edge fundamental research and direct transfer of new knowledge into society. Over 30,000 people from more than 120 countries find our university to be a place that promotes independent thinking and an environment that inspires excellence. Located in the heart of Europe, yet forging connections all over the world, we work together to develop solutions for the global challenges of today and tomorrow.